DEFINITIVE HEALTHCARE CORP (DH) Stock Fundamental Analysis
USA - NASDAQ:DH - US24477E1038 - Common Stock
2.85 USD
-0.02 (-0.7%)
Overall DH gets a fundamental rating of 3 out of 10. We evaluated DH against 35 industry peers in the Health Care Technology industry. DH may be in some trouble as it scores bad on both profitability and health. DH is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DH had positive earnings in the past year.
In the past year DH had a positive cash flow from operations.
In the past 5 years DH always reported negative net income.
Each year in the past 5 years DH had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -39.57%, DH is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
DH's Return On Equity of -100.37% is on the low side compared to the rest of the industry. DH is outperformed by 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -39.57% | ||
| ROE | -100.37% | ||
| ROIC | N/A |
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DH has a Gross Margin of 76.35%. This is amongst the best in the industry. DH outperforms 85.71% of its industry peers.
DH's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DH so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.35% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
2. Health
2.1 Basic Checks
DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DH has less shares outstanding
The number of shares outstanding for DH has been increased compared to 5 years ago.
The debt/assets ratio for DH is higher compared to a year ago.
2.2 Solvency
DH has an Altman-Z score of -0.41. This is a bad value and indicates that DH is not financially healthy and even has some risk of bankruptcy.
DH has a Altman-Z score (-0.41) which is comparable to the rest of the industry.
DH has a debt to FCF ratio of 4.10. This is a neutral value as DH would need 4.10 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.10, DH is doing good in the industry, outperforming 65.71% of the companies in the same industry.
DH has a Debt/Equity ratio of 0.53. This is a neutral value indicating DH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.53, DH is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 4.1 | ||
| Altman-Z | -0.41 |
ROIC/WACCN/A
WACC9.9%
2.3 Liquidity
A Current Ratio of 1.65 indicates that DH should not have too much problems paying its short term obligations.
The Current ratio of DH (1.65) is worse than 68.57% of its industry peers.
DH has a Quick Ratio of 1.65. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.65, DH is doing worse than 68.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.65 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
DH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.59%.
DH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.31%.
DH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.15% yearly.
EPS 1Y (TTM)-20.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-4.23%
3.2 Future
DH is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.78% yearly.
Based on estimates for the next years, DH will show a decrease in Revenue. The Revenue will decrease by -0.46% on average per year.
EPS Next Y-33.05%
EPS Next 2Y-12.53%
EPS Next 3Y-4.78%
EPS Next 5YN/A
Revenue Next Year-4.79%
Revenue Next 2Y-2.09%
Revenue Next 3Y-0.46%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.56, the valuation of DH can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of DH indicates a rather cheap valuation: DH is cheaper than 97.14% of the companies listed in the same industry.
DH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.35.
A Price/Forward Earnings ratio of 10.64 indicates a reasonable valuation of DH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DH indicates a rather cheap valuation: DH is cheaper than 88.57% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 33.72. DH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.56 | ||
| Fwd PE | 10.64 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DH is valued cheaper than 97.14% of the companies in the same industry.
94.29% of the companies in the same industry are more expensive than DH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.84 | ||
| EV/EBITDA | 6.36 |
4.3 Compensation for Growth
DH's earnings are expected to decrease with -4.78% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.53%
EPS Next 3Y-4.78%
5. Dividend
5.1 Amount
DH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DH (11/12/2025, 9:36:05 AM)
2.85
-0.02 (-0.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners34.09%
Inst Owner Change-0.17%
Ins Owners7.79%
Ins Owner Change11.95%
Market Cap406.07M
Revenue(TTM)252.20M
Net Income(TTM)-304.75M
Analysts74.29
Price Target4.57 (60.35%)
Short Float %12.81%
Short Ratio12.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)68.99%
Min EPS beat(2)36.39%
Max EPS beat(2)101.59%
EPS beat(4)4
Avg EPS beat(4)42.37%
Min EPS beat(4)9.63%
Max EPS beat(4)101.59%
EPS beat(8)6
Avg EPS beat(8)24.89%
EPS beat(12)10
Avg EPS beat(12)29.77%
EPS beat(16)12
Avg EPS beat(16)22.12%
Revenue beat(2)1
Avg Revenue beat(2)0.94%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)2.29%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)2.29%
Revenue beat(8)1
Avg Revenue beat(8)-1.12%
Revenue beat(12)2
Avg Revenue beat(12)-1.1%
Revenue beat(16)5
Avg Revenue beat(16)-0.73%
PT rev (1m)0%
PT rev (3m)9.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.71%
EPS NY rev (1m)0%
EPS NY rev (3m)6.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.56 | ||
| Fwd PE | 10.64 | ||
| P/S | 1.66 | ||
| P/FCF | 9.84 | ||
| P/OCF | 6.45 | ||
| P/B | 1.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.36 |
EPS(TTM)0.27
EY9.47%
EPS(NY)0.27
Fwd EY9.4%
FCF(TTM)0.29
FCFY10.16%
OCF(TTM)0.44
OCFY15.5%
SpS1.72
BVpS2.13
TBVpS-1.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -39.57% | ||
| ROE | -100.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.35% | ||
| FCFM | 16.85% |
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 4.1 | ||
| Debt/EBITDA | 3.51 | ||
| Cap/Depr | 39.87% | ||
| Cap/Sales | 8.85% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 137.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.65 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z | -0.41 |
F-Score4
WACC9.9%
ROIC/WACCN/A
Cap/Depr(3y)14.76%
Cap/Depr(5y)11.57%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
EPS Next Y-33.05%
EPS Next 2Y-12.53%
EPS Next 3Y-4.78%
EPS Next 5YN/A
Revenue 1Y (TTM)0.31%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-4.23%
Revenue Next Year-4.79%
Revenue Next 2Y-2.09%
Revenue Next 3Y-0.46%
Revenue Next 5YN/A
EBIT growth 1Y63.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-8.63%
EBIT Next 3Y-6.61%
EBIT Next 5YN/A
FCF growth 1Y67.56%
FCF growth 3Y35.38%
FCF growth 5Y18.42%
OCF growth 1Y88.1%
OCF growth 3Y32.16%
OCF growth 5Y21.93%
DEFINITIVE HEALTHCARE CORP / DH FAQ
Can you provide the ChartMill fundamental rating for DEFINITIVE HEALTHCARE CORP?
ChartMill assigns a fundamental rating of 3 / 10 to DH.
What is the valuation status for DH stock?
ChartMill assigns a valuation rating of 7 / 10 to DEFINITIVE HEALTHCARE CORP (DH). This can be considered as Undervalued.
Can you provide the profitability details for DEFINITIVE HEALTHCARE CORP?
DEFINITIVE HEALTHCARE CORP (DH) has a profitability rating of 2 / 10.
What is the financial health of DEFINITIVE HEALTHCARE CORP (DH) stock?
The financial health rating of DEFINITIVE HEALTHCARE CORP (DH) is 3 / 10.